CID 23649154

Tegobuvir

Structural Information

Molecular Formula
C25H14F7N5
SMILES
C1=CC=C(C(=C1)C2=NC3=CN(C=CC3=N2)CC4=NN=C(C=C4)C5=C(C=C(C=C5)C(F)(F)F)C(F)(F)F)F
InChI
InChI=1S/C25H14F7N5/c26-19-4-2-1-3-17(19)23-33-21-9-10-37(13-22(21)34-23)12-15-6-8-20(36-35-15)16-7-5-14(24(27,28)29)11-18(16)25(30,31)32/h1-11,13H,12H2
InChIKey
XBEQSQDCBSKCHJ-UHFFFAOYSA-N
Compound name
5-[[6-[2,4-bis(trifluoromethyl)phenyl]pyridazin-3-yl]methyl]-2-(2-fluorophenyl)imidazo[4,5-c]pyridine
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

20
References

1331
Patents

517.1138 Da
Monoisotopic Mass

4.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 518.12108 196.5
[M+Na]+ 540.10302 203.2
[M+NH4]+ 535.14762 196.9
[M+K]+ 556.07696 199.9
[M-H]- 516.10652 192.7
[M+Na-2H]- 538.08847 199.9
[M]+ 517.11325 196.1
[M]- 517.11435 196.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe